Mineralys Therapeutics, Inc. · NASDAQ:MLYS

Rodman David Malcom sold 2,171 Mineralys Therapeutics, Inc. shares (Form 4)

Traded Jul 9, 2026 · Filed Jul 10, 2026

On Jul 9, 2026, Rodman David Malcom (Chief Medical Officer) sold 2,171 Mineralys Therapeutics, Inc. shares at US$30.30 for US$65,781 under a trading plan, leaving 57,733 shares. Filed Jul 10, 2026 (Form 4).

Sold
2,171 shares
Price
US$30.30
Value
US$65,781
Holding after
57,733 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 9, 2026Common StockOption exercise2,171US$16.0059,904Direct
Jul 9, 2026Common StockSale2,171US$30.3057,733Direct

Source

View original at SEC

Related